GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Dipna Pharmachem Ltd (BOM:543594) » Definitions » Common Stock

Dipna Pharmachem (BOM:543594) Common Stock : ₹240 Mil (As of Sep. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Dipna Pharmachem Common Stock?

Dipna Pharmachem's quarterly common stock increased from Sep. 2023 (₹120 Mil) to Mar. 2024 (₹240 Mil) but then stayed the same from Mar. 2024 (₹240 Mil) to Sep. 2024 (₹240 Mil).

Dipna Pharmachem's annual common stock increased from Mar. 2022 (₹0 Mil) to Mar. 2023 (₹120 Mil) and increased from Mar. 2023 (₹120 Mil) to Mar. 2024 (₹240 Mil).


Dipna Pharmachem Common Stock Historical Data

The historical data trend for Dipna Pharmachem's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dipna Pharmachem Common Stock Chart

Dipna Pharmachem Annual Data
Trend Mar20 Mar21 Mar22 Mar23 Mar24
Common Stock
0.35 0.35 0.35 119.70 240.45

Dipna Pharmachem Semi-Annual Data
Mar20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24
Common Stock Get a 7-Day Free Trial Premium Member Only 119.70 119.70 119.70 240.45 240.45

Dipna Pharmachem Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.


Dipna Pharmachem Business Description

Traded in Other Exchanges
N/A
Address
A/211, Siddhi Vinayak Complex, Near D.A.V. School, Makarba, Ahmedabad, GJ, IND, 380055
Dipna Pharmachem Ltd is engaged in the trading and distribution of a wide range of pharmaceutical raw materials which is also known as APIs (Active Pharmaceutical Ingredients), Excipient and chemical formulation products. The company's product portfolio comprises of Hydrocortisone Acetate, Aceclofenac, Asprin, Levofloxacin, and others.

Dipna Pharmachem Headlines

No Headlines